Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NORVIR 80 MG

RITONAVIR : 80 MG · DIN 02229145 · ABBVIE CORPORATION

Health Canada status: CANCELLED POST MARKET

What is NORVIR?

NORVIR 80 MG contains RITONAVIR : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02229145, held by ABBVIE CORPORATION, supplied as SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What else is NORVIR called?

The same molecule, RITONAVIR, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
RITONAVIRLatinBrazil
Ritonavir ViatrisLatinSweden
Norvir Oral PowderLatinSouth Africa
Norvir®LatinUnited Arab Emirates
PaxlovidLatinSaudi Arabia
RinavoLatinSouth Africa
Ritonavir AccordLatinSweden

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Product details and regulatory record

DIN02229145
Brand nameNORVIR
Generic / active ingredientRITONAVIR : 80 MG
ManufacturerABBVIE CORPORATION
Strength80 MG
Dosage formSOLUTION
Route of administrationORAL
SchedulePrescription
ATC codeJ05AE03 RITONAVIR
AHFS class08:18.08.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date31-Mar-2019
Original market date1996-09-25 00:00:00

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)02229145
DIN (unpadded, as printed on some documents)2229145
Brand nameNORVIR
Active ingredient / INNRITONAVIR : 80 MG
ATC codeJ05AE03
ATC anatomical main groupJ — Anti-infectives for systemic use
ATC therapeutic subgroupJ05
AHFS class08:18.08.08
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderABBVIE CORPORATION

Health Canada approved product monograph (PDF)

Which pack is which?

Strength on the label80 MG
Dosage formSOLUTION
RouteORAL

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

What can be used instead?

Other Canadian products sharing ATC code J05AE03 RITONAVIR. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AURO-RITONAVIR100 MGTABLETAURO PHARMA INCMARKETEDDIN 02523620
NORVIR100 MGTABLETABBVIE CORPORATIONMARKETEDDIN 02357593
NORVIR100 MGCAPSULEABBVIE CORPORATIONCANCELLED POST MARKETDIN 02229137
NORVIR SEC100 MGCAPSULEABBVIE CORPORATIONCANCELLED POST MARKETDIN 02241480

Who else supplies RITONAVIR worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. RITONAVIR appears in 33 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How much does RITONAVIR cost around the world?

RITONAVIR is listed on 12 national price registers Nexara tracks, across 36 pack listings published on 11 different price bases. What each country publishes is set out below.

MarketWhat that country publishesBrands listedPack listingsAs of
SwedenAIP (pharmacy purchase price)3703 Sep 2026
South Africasingle exit price6601 Sep 2026
United Statesacquisition1503 Sep 2026
Italyex-factory (classe H)3402 Sep 2026
Romaniamax producer price3403 Sep 2026
Brazilpreco fabrica (ex-factory ceiling)2302 Sep 2026
Saudi Arabiapublic2201 Sep 2026
United Arab Emiratespublic1131 Aug 2026
Australiaex-manufacturer1108 Sep 2026
Greeceproducer price (ex-factory)1103 Sep 2026
Norwaymax AUP (pharmacy retail)1107 Sep 2026
Slovakiacategorised final price1102 Sep 2026

Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.

Ask Nexara for a landed Canadian price

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02229145. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.